| Solubility enhancement of poorly soluble drugs by solid dispersion technique–A review V Kamalakkannan, A Puratchikody, K Masilamani, B Senthilnathan J. Pharm. Res 3 (9), 2314-2321, 2010 | 75 | 2010 |
| Development and evaluation of chitosan based polymeric nanoparticles of an antiulcer drug lansoprazole E Nagarajana, P Shanmugasundarama, V Ravichandirana, ... Journal of Applied Pharmaceutical Science 5 (4), 020-025, 2015 | 49 | 2015 |
| Promising upshot of silver nanoparticles primed from Gracilaria crassa against bacterial pathogens V Lavakumar, K Masilamani, V Ravichandiran, N Venkateshan, ... Chemistry Central Journal 9, 1-8, 2015 | 41 | 2015 |
| Quercetin-decorated curcumin liposome design for cancer therapy: in-vitro and in-vivo studies V Ravichandiran, K Masilamani, B Senthilnathan, A Maheshwaran, ... Current Drug Delivery 14 (8), 1053-1059, 2017 | 29 | 2017 |
| Enhancement of drugs bioavailability by floating drug delivery system-A review V Kamalakkannan, A Puratchikody, VV Prasanth, K Masilamani International Journal of Drug Delivery 3 (4), 558, 2011 | 27 | 2011 |
| Determination of ionization constant (pKa) for poorly soluble drugs by using surfactants: a novel approach V Ravichandiran, V Devarajan, K Masilamani Der Pharmacia Lettre 3 (4), 183-92, 2011 | 22 | 2011 |
| Liposome-a versatile drug delivery system V Ravichandiran, B Senthilnathan Der Pharmacia Sinica, 2011 | 19 | 2011 |
| Community pharmacists’ attitudes towards use of medicine in rural India–An analysis of the current situation SC Basak, A Arunkumar, K Masilamani Int Pharm J 16 (2), 32-35, 2002 | 18 | 2002 |
| Liposomal drug delivery systems—a review A Maheswaran, P Brindha, AR Mullaicharam, K Masilamani Int J Pharm Sci Rev Res 23 (1), 295-01, 2013 | 17 | 2013 |
| Analytical method development and validation for Candesartan Cilexetil as bulk drug and in pharmaceutical dosage forms by HPLC V Kamalakkannan, A Puratchikody, K Masilamani, T Saraswathy Der Pharmacia Lettre 3 (3), 286-296, 2011 | 13 | 2011 |
| In vitro antioxidant and anticancer activity of flavonoids from Cassia tora linn. leaves against human breast carcinoma cell lines. A Vijayalakshmi, K Masilamani, E Nagarajan, V Ravichandiran | 12 | 2015 |
| Effect of formulation and process variables on drug content and entrapment efficiency of aceclofenac nanosuspension RV Masilamani K International Research Journal of Pharmacy 3 (3), 315-318, 2012 | 12 | 2012 |
| Anti-Psoriatic activity of smilax china linn. rhizome A Vijayalakshmi, V Ravichandiran, M Velraj, S Nirmala, M Anusha, ... IJPER 47 (1), 82-89, 2013 | 11 | 2013 |
| Development and evaluation of gastroretentive formulations for moxifloxacin hydrochloride RK Gunda, A Vijayalakshmi, K Masilamani The Thai Journal of Pharmaceutical Sciences 44 (1), 30-39, 2020 | 9 | 2020 |
| Design and development of dexibuprofen loaded chitosan nanoparticles B Senthilnathan, K Gopalasatheeskumar, A Vijayalakshmi, E Bhavya, ... Drug Invent. Today 10 (2), 2018 | 9 | 2018 |
| Fast dissolving tablets: A Review V Ravichandiran, K Masilamani, SS Kumar, T Kumaragurubaran, ... Journal of Pharmacy Research 4 (8), 2590-2592, 2011 | 9 | 2011 |
| Formulation development and evaluation of Tamsulosin Hydrochloride and Dutasteride in tablet dosage form V Ravichandiran, B Senthilnathan Der Pharmacia Sinica, 2011 | 9 | 2011 |
| Anti-psoriatic activity of flavonoids from the bark of Givotia rottleriformis Griff A Vijayalakshmi, M Geetha, V Ravichandiran, K Masilamani Ex Wight Iranian J Pharma Sci 10, 81-94, 2014 | 8 | 2014 |
| DRUG DELIVERY TO THE LUNGS V Ravichandiran, K Masilamani, S Satheshkumar, D Joseprakash International journal of pharmaceutical sciences review and research 10 (2 …, 2011 | 8 | 2011 |
| Pulsatile drug delivery systems MK Ravichandiran V, Suba V, Senthilnathan B, Rajachandrika K, Padmapriya S ... Biomedical and Pharmacology journal 2 (2), 227-234, 2009 | 8* | 2009 |
